LYMPHOMA, SMALL LYMPHOCYTIC

Clinical trials for LYMPHOMA, SMALL LYMPHOCYTIC explained in plain language.

Never miss a new study

Get alerted when new LYMPHOMA, SMALL LYMPHOCYTIC trials appear

Sign up with your email to follow new studies for LYMPHOMA, SMALL LYMPHOCYTIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 3 Not yet recruiting 1

Five-Year watch begins for cancer Drug's Long-Term effects

Disease control Not yet recruiting

This study aims to monitor the long-term safety of the drug pirtobrutinib in people with a type of blood cancer called chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). It is open only to 150 people who have already completed a specific earlier trial of this…

Matched conditions: LYMPHOMA, SMALL LYMPHOCYTIC

Phase: PHASE4 • Sponsor: Eli Lilly and Company • Aim: Disease control

Last updated Apr 02, 2026 14:56 UTC

LYMPHOMA, SMALL LYMPHOCYTIC

Get alerted when new LYMPHOMA, SMALL LYMPHOCYTIC trials appear

Five-Year watch begins for cancer Drug's Long-Term effects